SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zeneca Group plc (NYSE ticker ZEN) -- Ignore unavailable to you. Want to Upgrade?


To: DavesM who wrote (18)6/23/1998 8:13:00 PM
From: DavesM  Read Replies (1) | Respond to of 75
 
Zeneca Diagnostics test for cancer is now available in Europe
biz.yahoo.com

The test detects 7 common mutations of the K-Ras oncogene. Zen claims that these mutations are implicated in 25% of lung cancers, 50% of colon cancers, and 90% of pancreatic cancers.